Rising rates of depression amid the coronavirus pandemic underscore the need for innovations in mental health care, like psychedelics, according to George Goldsmith, CEO, chairman, and co‑founder of mental health company COMPASS Pathways.
"About 322 million people suffer from depression around the world — and that was before this current pandemic — but about 100 million of those just aren't helped by current treatment," Goldsmith told Cheddar. "So we really focused a lot on, 'how do we bring innovation to patients?'"
COMPASS Pathways is a United Kingdom-based biotech startup, researching a synthetic form of the psychedelic compound, psilocybin, for treatment resistant depression. Its drug, called COMP360, received "breakthrough therapy designation" from the U.S. Food and Drug Administration in 2018, meaning there was evidence it could substantially improve treatment over existing therapies and could move more quickly through drug development.
"We're working closely with regulators in every country that we're working with to develop clinical trials, and if those clinical trials are successful, then those medicines will be made available to patients," Goldsmith said.
The time is right for innovations in mental health care. Stressors related to the coronavirus pandemic may have tripled rates of depression across the U.S., according to a survey published in JAMA Network Open in early September. Some 27.8 percent of adults reported experiencing depression symptoms amid the pandemic, compared with 8.5 percent previously, according to the survey results. And the burden fell disproportionately on people who had limited financial or social resources.
"A single experience, a single dose of psilocybin for many people, can create an immediate and sustained benefit for people suffering with depression. And that really intrigued us," Goldsmith said.
COMPASS Pathways debuted on Nasdaq in September in a $146.6 million upsized initial public offering. It's move kicked off a flurry of interest from other psychedelic health and wellness companies looking to go public or uplist for similar access to liquidity and investors. Goldsmith said that for COMPASS Pathways, the move was motivated by expenses associated with the research the company is doing in nine countries.
"We're committed to really addressing mental health care at scale, and capital, shareholder capital, really helps with that," Goldsmith said.
James Gallagher, CEO and Co-Founder of GreenLite, discusses the challenges of rebuilding the fire-affected LA area and how permitting complicates the process.
Super Bowl Champion, Julian Edelman, talks Chiefs' conspiracies, his fave TSwift song and his bet for Super Bowl LIX. Plus, the best time for a bathroom break.
Ron Hammond, Sr. Director of Government Relations at the Blockchain Association, breaks down Trump’s plan to strengthen U.S. leadership in financial technology.
BiggerPockets Money podcast is now available on Cheddar Wednesdays at 10am ET! Mindy Jensen shares how her podcast is helping people gain financial freedom.
The social video platform's future remains in doubt, as players scramble to profit from the chaos. Plus: Big oil gets bigger, DOGE downsizes, and tariffs!
Ty Young, CEO of Ty J. Young Wealth Management, joins Cheddar to discuss Trump's moves as he returns to Washington D.C. and how it may affect the U.S. economy.
Starbucks’ decision to restrict its restrooms to paying customers has flushed out a wider problem: a patchwork of restroom use policies that varies by state and city. Starbucks announced last week a new code of conduct that says people need to make a purchase if they want to hang out or use the restroom. The coffee chain's policy change for bathroom privileges has left Americans confused and divided over who gets to go and when. The American Restroom Association, a public toilet advocacy group, was among the critics. Rules about restroom access in restaurants vary by state, city and county. The National Retail Federation says private businesses have a right to limit restroom use.
President Donald Trump is talking up a joint venture investing up to $500 billion for infrastructure tied to artificial intelligence by a new partnership formed by OpenAI, Oracle and SoftBank. The new entity, Stargate, will start building out data centers and the electricity generation needed for the further development of the fast-evolving AI in Texas, according to the White House. The initial investment is expected to be $100 billion and could reach five times that sum. While Trump has seized on similar announcements to show that his presidency is boosting the economy, there were already expectations of a massive buildout of data centers and electricity plants needed for the development of AI.
